Karyopharm Therapeutics: Q2 Earnings Insights

Karyopharm Therapeutics KPTI reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Karyopharm Therapeutics beat estimated earnings by 1.59%, reporting an EPS of $-0.62 versus an estimate of $-0.63.

Revenue was up $17.08 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 9.79% drop in the share price the next day.

Here's a look at Karyopharm Therapeutics's past performance:

To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.